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Abstract: Progress in unravelling the cellular and
molecular basis of mammalian circadian regulation over
the past decade has provided us with new avenues
through which we can explore central nervous system
disease. Deteriorations in measurable circadian output
parameters, such as sleep/wake deficits and dysregulation
of circulating hormone levels, are common features of
most central nervous system disorders. At the core of the
mammalian circadian system is a complex of molecular
oscillations within the hypothalamic suprachiasmatic
nucleus. These oscillations are modifiable by afferent
signals from the environment, and integrated signals are
subsequently conveyed to remote central neural circuits
where specific output rhythms are regulated. Mutations in
circadian genes in mice can disturb both molecular
oscillations and measurable output rhythms. Moreover,
systematic analysis of these mutants indicates that they
can express an array of abnormal behavioural phenotypes
that are intermediate signatures of central nervous system
disorders. Furthermore, the response of these mutants to
psychoactive drugs suggests that clock genes can modify
a number of the brain’s critical neurotransmitter systems.
This evidence has led to promising investigations into
clock gene polymorphisms in psychiatric disease. Prelim-
inary indications favour the systematic investigation of
the contribution of circadian genes to central nervous
system disease.
Introduction
The correct functioning of the endogenous circadian clock
enables organisms to anticipate daily environmental changes and
temporally modify behavioural and physiological functions
appropriately. All organisms maintain a large number of
physiological variables (sleep-wake cycle, locomotor activity,
temperature regulation, water/food intake, and levels of circulat-
ing hormones) under control of the circadian clock. There are
well-known consequences of disrupted circadian function outside
of the brain; metabolism, reproduction, and even longevity can be
adversely affected when the means of determining time of day are
altered at a molecular level (for review see [1]). Perhaps less has
been said regarding the brain and the idea that altered clock
function may contribute to neurological, behavioural, and
psychiatric deterioration. Here, we explore the contribution of
this complex circadian system to brain function in physiological
and diseased states. Following a description of the molecular and
neural basis of mammalian circadian oscillations and their
relationship to brain function, we consider the wider behavioural
effects of mutations and ablations of circadian system genes in
mice. Furthermore, we explore the persistent observation of
rhythm misregulation in psychiatric and neurological disorders
and in their related mouse models. Finally, in considering the
contribution of circadian regulation to disease symptomatology,
we examine the association between clock gene polymorphisms
and behavioural traits and disorders in humans. Although sparse,
these reports suggest that clock gene misregulation can contribute
to the severity of a broad spectrum of central nervous system
(CNS) diseases.
Molecular and Neural Basis of Mammalian
Circadian Oscillations
The suprachiasmatic nucleus (SCN) of the hypothalamus is the
centre for the circadian system in the mammalian brain [2].
Through its neuronal and humoral outputs, the SCN can
orchestrate a number of physiological and behavioural rhythms
throughout the body. Perhaps surprisingly, these circadian rhythms
are not derived from the multicellular network properties of the
SCN but are in fact generated at a cell autonomous level. The
endogenous clock is fundamentally encoded, at the molecular level,
by interlocking autoregulatory transcriptional and translational
feedback loops within every cell (see [1,3] for reviews and Figure 1
for description). The same coordinated molecular circadian
rhythms have been identified in a number of cell types, tissues,
and organs throughout the body. This observation also applies to a
wide range of CNS regions, including the olfactory bulb, pituitary,
pineal gland, arcuate nucleus, and retina [4–11]. Importantly, it
has been established that these rhythms are not externally driven by
the output of the SCN, and the time or phase at which particular
gene products peak is often region-specific [4,5].
Aside from generating robust rhythms, the circadian system
must be sensitive to environmental cues and be able to adjust its
phase to synchronise with the prevailing day/night rhythm, a
process known as entrainment. In mammals, the signalling of
environmental light exposure, carried by dedicated retinal
afferents, is the most important entrainment cue of the SCN
clock [12]. However, other cues such as food availability, novel
environment, or social interaction may act as timekeeping cues
(Figure 2). These signals reach the SCN clock through disparate
neurotransmitter/neuromodulator and hormonal pathways and
can reset the phase of expression within the autoregulatory
feedback loops [13–16]. Non-SCN clocks can be directly sensitive
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retina [10,11], although there is evidence that additional, extra-
SCN oscillators receive relevant environmental phase-setting
information directly [17–19]. However, as they also receive strong
entrainment signals from the SCN [6,8], it is a process of
bidirectional communication and feedback that ultimately estab-
lishes the entrainment and phasing of molecular clocks throughout
the brain and body. A final level of complexity and fine-tuning in
molecular rhythms may also be derived from local crosstalk
between clock tissues and nuclei (reviewed in [8]).
For molecular circadian rhythms to have an impact on
physiology and behaviour, they must be converted into function-
ally relevant outputs. This is achieved by complex spatiotemporal
regulation of gene expression that impacts on cell/tissue-specific
function. The orchestrated expression of a number of so-called
clock-controlled genes (CCGs) then dictates the temporal
regulation of clock-output/functional rhythms in brain regions/
systems and peripheral tissues. These may take the form of altered
hormone release, changes in action potential firing rate, modified
rates of cellular metabolism, etc. [3].
All of the above indicates that the generation of daily rhythms in
behavioural and physiological functions, together with the ability
to integrate a range of environmental inputs, relies on a complex
circadian system. And evidently this system relies on the action of
many genes. Moreover, novel genetic factors that influence
circadian parameters continue to be identified in mutagenesis
screens [20,21], in QTL analyses [22,23], and in protein
interaction studies [24].
Neurological and Behavioural Phenotypes in
Mouse Clock Mutants
Molecular-genetic modifications of the circadian system have a
wide range of effects depending on the particular gene affected
and also the nature of the mutation (Figure 1). Investigation of
mouse clock mutants has focussed primarily on circadian
behaviour by assessing overt activity rhythms and molecular
rhythms in the SCN. The effects of circadian gene manipulation
can range from the profound (complete loss of behavioural and
molecular rhythmicity in constant conditions [25–27]) to subtle
effects (e.g., altered phasing of behavioural/molecular rhythms
[28]). However, a more systematic behavioural characterisation of
mouse clock mutants could potentially uncover novel behavioural
phenotypes associated with clock genes. Given the role of the SCN
molecular oscillator in synchronising and entraining neural
rhythms in discrete brain centres, clock mutants might affect
Figure 1. The Mammalian Molecular Circadian Oscillator. The molecular circadian oscillator incorporates numerous transcriptional and
posttranslational elements. Disruptions in many of the individual circadian elements in mice can lead to behavioural disturbances that mirror
endophenotypes in human neurological and psychiatric disorders. Moreover, some studies have established circadian genepolymorphisms in psychiatric
conditions and mutations in behavioural syndromes (see text for details). The central component of the figure depicts the core mammalian circadian
feedback loop. CLOCK(or NPAS2):BMAL1 heterodimers drive the transcription of multiple genes (Cry1/2, Per1-3, Rev-Erba/b, Rora/b/c, multiple CCGs)
through E-box elements. Nuclear accumulation of CRY and PER proteins can inhibit CLOCK:BMAL1-mediated transcription by directly interacting with the
complex (black bar–ended arrow). As PER and CRY levels fall, the negative repression is lifted and CLOCK:BMAL1-driven transcription re-occurs. In an
additional stabilising loop, REV-ERB and ROR proteins co-regulate the transcription of Bmal1 by competing for RREs in its promoter sequence. Rhythmic
output of the clock is achieved through E-box elements in CCG which can impact a range of cell processes and physiology. The stability and subcellular
localisation ofcircadianproteins is highly regulatedbykinases andphosphatases (inset box).Although not entirelyunderstood, thephosphorylationstate
ofcircadian proteinscanaffect theircellularlocalisationand/orstability.Mutationsaffectingthestability ofPer proteins canacceleratethe molecularclock
in humans, leading to the inherited syndrome familial advanced sleep phase syndrome (FASPS).
doi:10.1371/journal.pgen.1000040.g001
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function, a deficit in discrete brain region oscillator function, or
as a secondary consequence of specific neural rhythm dysfunction.
Disturbances in sleep parameters are associated with a spectrum
of neurological and psychiatric disorders. Sleep patterns are
affected not only by circadian timing mechanisms but also by
independent homeostatic mechanisms that determine the amount
of sleep required [29]. Analysis of sleep parameters predicts that
mechanisms other than the regulation of sleep-wake timing are
affected in clock mutants, as sleep anomalies in clock mutants do
not always mirror the behavioural rhythm anomalies. Mutations
in Clock (MGI:1861634), Bmal1 (MGI:2180361), and Cry1
(MGI:1270841)/Cry2 (MGI:2181206) [30–32] result in alterations
in sleep time, sleep fragmentation, and atypical responses following
sleep deprivation. Similarly, a number of other clock-related genes,
including Npas2 (MGI:109232), Dbp (MGI:94866), and Prok2
(MGI:1354178) affect elements of sleep homeostasis [33–35].
However, further evidence exists for the functional segregation
of circadian and homeostatic regulation of sleep, as Per1
(MGI:2182834)/Per2 (MGI:1934020) double mutants show no
effects on sleep homeostatic mechanisms, although robust rhythms
of sleep and wakefulness are lost in constant conditions [36,37].
Thus, upon consideration of this data, effects of clock mutations on
sleep homeostasis could be related to pleiotropy or brain region
specificity of particular clock genes.
The process of memory formation in clock mutant mice has
received limited attention. Npas2 can deputise for Clock in
maintaining molecular rhythms in the SCN and is in fact the
normal binding partner for Bmal1 in forebrain clocks [9,38].
Mutants lacking Npas2 show deficits in the acquisition of cued and
contextual fear-conditioning paradigms [39]. It is not feasible that
the deficit in Npas2 null mice is secondary to major, centralised
circadian disruption, as these mice show only a subtle activity
phenotype. A pleiotropic, non-clock effect of Npas2 in memory
formation is one possible explanation. Alternatively, the loss of
Npas2 may abrogate particular extra-SCN brain clock(s) that
regulate memory formation. Evidence for the participation of
other clock genes in memory regulation is sparse. Although no
specific memory deficits have been found in Per1/Per2 mutant
mice [40], Drosophila Per mutants (FBgn0003068) are defective in
long-term memory formation [41]. In the same study, no memory-
associated deficits were found in timeless (FBgn0014396), clock
(FBgn0023076), and cycle (FBgn0023094) mutants, indicating that
an association between clock genes and memory regulation is not
universal and a degree of functional segregation exists within the
system.
There is increasing evidence that a dysfunctional circadian
system could be a primary cause of altered emotional behaviour.
The majority of this evidence in mice comes from studies on the
ENU-induced mutation Clock. Homozygous mutants have a
spectrum of behavioural abnormalities including low anxiety,
mania, and hyperactivity [42,43]. These behavioural abnormal-
ities are perhaps explicable by the direct effects of the Clock
mutation on core molecular circadian oscillations or are secondary
to an alteration in the dynamics of communication between CNS
clocks dysregulated by the altered function of the core oscillator. In
support of the second possibility, behavioural disturbances in
homozygotes are associated with increased dopaminergic activity
[42,43]. Further work strengthens the link between the circadian
system and mood regulation. Dysregulation of either NPY or VIP,
important neurotransmitters for signalling to and within the SCN,
can lead to a number of behavioural disturbances, including
alterations in anxiety-like behaviour and aggression [44,45].
The observations that the mood-stabilising agent, lithium, can
reverse behavioural disturbances in Clock mutant mice [43] adds to
an increasing body of evidence that lithium’s therapeutic effects
may be partially mediated through its effects on the circadian
system. Lithium is a potent inhibitor of glycogen synthase kinase
Figure 2. The Circadian System and the Mammalian Brain. The SCN acts as a ‘‘master’’ clock, sending neuronal and humoral output to a
number of regions in the CNS. The SCN can passively drive rhythmicity in these regions, or nuclei may themselves have their own automomous
clocks. Within the SCN, every cell is a potentially independent oscillator unit. Extensive intra-SCN signalling is used to synchronise the rhythms of
multiple cells. Entrainment is a process whereby environmental stimuli can alter the timing or phase of central rhythms so that they are coincidental
with the prevailing daily cycle (far left). Time cues reach the SCN via several pathways involving intermediate brain areas. Some of these relay nuclei
may contain their own oscillators and/or have rhythms in their function (blue and orange arrows and oscillators). Others may not have rhythmic
function (green arrow). Extra-SCN oscillators may directly utilise time cues (blue and orange oscillators) or may rely solely on the SCN to synchronise/
entrain rhythms (lilac arrows to grey oscillators). These oscillators may also provide feedback which impacts on the operation of the SCN (grey return
arrows). In addition, extra-SCN oscillators may drive/influence rhythmicity in other brain areas (smaller grey oscillator) and communicate with each
other independently from the SCN (reciprocal grey arrows). Within the CNS, some neurotransmitters/neuromodulators involved in signalling are
indicated. The overall output of this complex system (large red arrow) creates the daily rhythmicity seen in a range of neurological functions and
behaviours (far right). There is a wider communication with clock/oscillator units throughout the entire body. However, these so-called ‘‘peripheral’’
oscillators and their actions are not shown here.
doi:10.1371/journal.pgen.1000040.g002
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logue, shaggy (FBgn0003371), can lengthen the circadian period [46].
In mammalian systems, GSK3b can mediate its circadian effects
through promoting the nuclear expression and stability of a number
of clock proteins [47,48]. Moreover, in cultured mammalian cells
lithium treatment leads to the rapid proteasomal degradation of the
clockprotein Rev-erba (MGI:2444210)and subsequent activation of
the clock gene Bmal1 (MGI:1096381) [48].
Additional evidence for behavioural disturbances in clock gene
mutants is supported by the fact that they appear to affect the
sensitisation to, and preference for, drugs of abuse. This was first
evidenced in a number of Drosophila mutants including period, clock,
cycle, and doubletime (FBgn0002413) [49], where sensitisation to the
effects of cocaine is eliminated. Similar effects were identified in
some mouse mutants, although some had opposite effects. For
example, mouse Per1 mutants show no behavioural sensitisation to
cocaine, and, in a conditioned place preference task, show no
preference to cocaine [50]. Per2 mutants have a hypersensitised
response to cocaine, and the place preference response is strong
[50]. Mice carrying the ENU-induced mutation Clock also show a
hypersensitive response to cocaine and increased place preference
[51]. These authors suggest that the increased expression and
phosphorylation of tyrosine hydroxylase in mutants may affect
dopaminergic function within the brain’s reward circuits. Effects of
clock mutants on the brain’s neurochemical systems are not
limited to the dopaminergic system. Expression of the glutamate
transporter Eaat1 (MGI:99917) is reduced in mouse Per2 mutants,
leading to decreased uptake of glutamate by astrocytes and
increased extracellular glutamate levels [52]. Moreover, increases
in alcohol consumption in Per2 mutant mice were reversed by
agents believed to act through reducing abnormally high
glutamatergic activity. Overall, the interactions between circadian
clocks and addiction mechanisms seem to be complex. The
possibility of pleiotropy in clock genes cannot be discounted,
although these effects could be dissected using conditional
mutants. Nevertheless, there is an increasing body of work
detailing the interaction between the circadian system and brain
neurotransmitter systems. As described above, clock gene
expression can be modulated by a number of afferent neurotrans-
mitter effects, and, conversely, the functions of efferent neuro-
transmitter systems/brain nuclei are modifiable by altered clock
gene expression [42,43,52].
Altered Circadian Parameters in CNS Disorders
Undoubtedly, circadian parameters are consistently disrupted in
a spectrum of CNS disorders (Table 1). In many cases, these
disruptions may be secondary to compromised neural circuitry
where brain regions regulating output rhythms are disturbed.
Nevertheless, it has been difficult to establish whether circadian
system disturbances can contribute to CNS disorders or whether
they are merely symptomatic of the disease process. In all
likelihood, disruption of circadian oscillators can at least modify
disease severity, whereas, in some instances, they may play a more
primary role in the aetiology of the disease.
In neurodegenerative disease and aging (Table 1), disturbances
in sleep mechanisms and circadian disturbances in phase and
amplitude of activity and temperature regulation are common
symptomatic features secondary to a deterioration in brain
circuitry [53–60]. Circadian activity disturbances have been
described in a number of transgenic mouse models of Alzheimer
Disease (AD, OMIM; #104300), and in some cases these precede
the onset of typical AD pathologies [61–64]. The neurodegener-
ative prion diseases also express a spectrum of sleep and circadian
rhythm disturbances [54,59,60]. Interestingly, these disturbances
are mirrored in mice that are null for the prion protein [65]. In the
Huntington R6/2 mouse transgenic line, disintegration of activity
rhythms mimic those seen in Huntington patients (OMIM;
+143100), and these behavioural disturbances are accompanied
by altered clock gene rhythms in the SCN, motor cortex, and
striatum [55]. Similarly, aging alters activity onsets, lengthens
circadian period, reduces circadian amplitude, and alters SCN
electrophysiology in mice [66,67]. Age-related circadian changes
may also be symptomatic of brain circuitry deterioration as, for
example, comparable effects of aging are seen in wild-type and
Clock mutant mice [68].
Circadian disturbances are more likely to contribute to the
aetiology of a number of syndromic disorders (Table 1). These
disturbances are likely to be due to deficits in specific oscillating
neural and molecular circuits that are regulated by the clock.
Smith-Magenis syndrome (SMS, OMIM #182290), associated
with heterozygous deletions on Chromosome 17, is characterised
by significant sleep disturbances with a reversed secretion rhythm
of melatonin [69–71]. Mice carrying an engineered heterozygous
deletion of the SMS syntenic region (Del(11Cops3-Zfp179)1Jrl,
MGI:3521985) have a hypoactive phenotype and an abnormal
circadian period [72]. Sleep disturbances are also features of Down
syndrome (OMIM #190685) patients [73–75], and the Ts65Dn
mouse mutant expresses a number of abnormal circadian param-
eters including increased activity in the light phase, a reduction in
rhythm amplitude, and a four-hour advance in the phase of activity
[76,77]. Patients with Prader-Willi syndrome (PWS, OMIM
#176270) also exhibit a spectrum of sleep-related and behavioural
disturbances [75,78,79]. Mice deficient for the mage-like 2 gene
(Magel2), an SCN-enriched transcript within the PWS deletion
region, have a reduced circadian activity amplitude with increased
daytime activity relative to controls (MGI:3760092) [80].
Other behavioural disorders with circadian and sleep-related
disturbances include autism spectrum disorders (ASD) (OMIM
%209850) [81]). Behavioural disturbances in ASD may arise in part
from an inability of an individual’s circadian oscillator to entrain to
environmentalandsocialcues.OnespecificcorrelateofASDisalow
level of melatonin, and one of the enzymes critical in the synthesis of
melatonin, acetylserotonin-O-methyltransferase (ASMT,O M I M
*300015), is implicated as a susceptibility gene for ASD [82].
Mutations in the phosphatase and tensin homologue on Chromo-
some ten (PTEN) have been reported in autistic individuals with
macrocephaly. In mice carrying a conditional deletion of Pten
(MGI:2182005), abnormal phenotypes include macrocephaly,
increased susceptibility to seizures, social interaction deficits, anxiety,
and a significantly longer free-running period [83].
The contribution of the circadian regulatory system, arising
from conflicts between internal biological clocks and environmen-
tal (solar) and social clocks, is evident in affective disorders. All
major affective disorders (such as unipolar depression, OMIM
#608516; bipolar disorder, and schizophrenia, OMIM #181500)
include circadian phase disturbances in sleep, activity, tempera-
ture, and hormone levels (for reviews see [84–86]). Moreover,
there is evidence that if rhythms can be altered/stabilised using
relevant therapies, improvements in the primary symptoms can
occur. For example, in some instances sleep deprivation has an
antidepressant effect in patients [87]. Conversely, many disorders
with a primary anomaly in the circadian system are associated
with depressed mood. Seasonal affective disorder (SAD; OMIM
#608516) is a common condition where depressive symptoms
occur during shorter winter days [88–90]. Two inherited sleep
phase disorders, familial advanced sleep phase syndrome (FASPS;
OMIM #604348) and delayed sleep phase syndrome (DSPS), are
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more, individuals with a behavioural preference for ‘‘eveningness’’
have a greater tendency to develop depression [93]. Because of the
difficulties in classifying these diseases/conditions in humans and
because of their multigenic nature, it is difficult to study their
aetiology in mouse models. However, although no mouse mutants
have been developed to model complete affective disorders, a
number of mutants in serotonergic and dopaminergic systems
displaying features of these disorders also show disturbances in
circadian phase and/or sleep parameters [94–97].
Polymorphisms in Human Clock Genes Alter More
Than Rhythms
The contribution of circadian gene dysregulation to CNS
disorders has only recently been explored through the analysis of
clock gene polymorphisms. Circadian gene polymorphisms may
simply underlie a morning or evening preference in human
populations, but extremes in these behaviours may also underlie
the more complex phenotypes associated with psychiatric
disorders. A quantitative scoring system for diurnal preference,
the Horne-Ostberg questionnaire [98], has been used as the basis
for association studies, and these have been carried out either in
random populations or in families inheriting FASPS or DSPS.
Many studies implicate altered dynamics in clock protein
phosphorylation as a critical factor (see Figure 1). For example,
the shorter 4-repeat allele of a 54-bp coding-region polymorphism
in the PER3 (OMIM *603427) gene is associated with extreme
evening preference and DSPS [99]. Moreover, in comparisons
between short- and long-repeat patients, slow wave sleep was
greater in 5-repeat individuals, and deficits in cognitive perfor-
mance following sleep loss were greater [100]. This 54-bp
sequence is in a region of PER3 encoding a putative phosphor-
ylation domain. The significance of these observations has been
highlighted by the identification of two distinct mutations in
familial ASPS pedigrees. The first [101], a mis-sense mutation in
Table 1. Rhythm/Sleep Endophenotypes in Human CNS Disease and in Mouse Models.
Human Disease or Condition Disturbed Rhythm/Sleep Endophenotype Relevant Phenotypes in Mouse Models
Familial advanced sleep phase
syndrome (FASPS)
Early sleep and wake times, shortened circadian rhythms
[112].
Mice expressing human mis-sense mutations in Per2 or CKId have
advanced phase of activity in a light-dark schedule and a
shortened activity rhythm [92,102].
Delayed sleep phase syndrome
(DSPS)
Extreme evening preference, delayed phase of activity, sleep,
core body temperature, and melatonin [113].
No model.
Seasonal affective disorder (SAD) Depressive symptoms occur during shorter winter days
[88–90].
No model.
Mood disorders (unipolar
depression) and psychoses
(schizophrenia, bipolar)
Depression. Increased sleep latency, impaired sleep continuity,
phase advance in endogenous circadian system relative to
sleep schedule, phase advances in growth hormone, plasma
melatonin, increased plasma cortisol at night. All major
affective disorders include circadian phase disturbances in
sleep, activity, temperature, and hormone levels (for reviews
see [84–86]).
No accurate mouse model. Mutants in serotonergic and
dopaminergic systems show disturbances in circadian phase and/
or sleep parameters [94–97]. Clock mutant has low anxiety,
mania, and hyperactivity [42,43]. Cognitive disturbances in Npas2
mutant [39]. Abnormal sensitisation to drugs of abuse in Clock
and Per mutants [50–52].
Autism spectrum disorders (ASD) Longer sleep latency and greater sleep fragmentation.
Abnormalities in circadian rhythm and mean concentration
of plasma melatonin [81].
Mice expressing a conditional deletion of Pten have a significantly
longer free-running period [83].
Down syndrome Reduced sleep maintenance, sleep fragmentation, reduction
in percent REM sleep, sleep apnea [73–75].
Ts65Dn mouse mutant shows increased activity in the light
phase, a reduction in rhythm amplitude, and a 4-h advance in the
phase of activity [76,77].
Smith-Magenis syndrome Inverted rhythm of melatonin secretion [69,71]. Advanced
sleep/wake phase. Nighttime wakening, daytime sleepiness.
Reduced total and NREM sleep [70].
Heterozygous deletion mutant mice have a hypoactive
phenotype and a significantly shorter circadian period [72].
Prader-Willi syndrome Sleep apnea, sleep-related and behavioural disturbances
including daytime napping and excessive daytime sleepiness
[75,78,79].
Mice deficient for mage-like 2 gene (Magel2) have a reduced
circadian activity amplitude with increased daytime activity [80].
Parkinson disease (PD) Sleep fragmentation, sleep apnea, REM sleep behaviour
disorder, excessive daytime sleepiness [53].
No recorded circadian or sleep disturbances in genetic mouse
models [114].
Huntington disease (HD) Nocturnal awakening and progressive disintegration of daily
activity rhythms [55].
R6/2 mouse transgenic line has increased daytime and reduced
nocturnal activity. Progresses to a complete disintegration of
diurnal and circadian activity rhythms [55].
Alzheimer disease (AD) Fragmented sleep, increased nocturnal activity, and reduced
daytime activity. Delayed phase in peak of daily activity [57].
Alterations in sleep regulation and timing in Tg2576 [62] and
PDAPP mice [61]. Tg2576 mice also have a significantly longer
circadian period [62]. Both TgCRND8 and APP23 mice show
changes in daily activity profiles potentially analogous to those
seen in AD patients [63,64].
Aging Sleep disturbances due to earlier wake time and reduced
sleep consolidation. Partially attributed to age-related
reduction in amplitude and advance in phase of circadian
rhythms [56,58].
Aging lengthens the period and reduces the amplitude of
circadian activity rhythms. The onset of daily activity is
significantly delayed and the variability of onset is increased [67].
Prion diseases Severe sleep abnormalities, progressive loss of circadian
rest-activity, and melatonin rhythms [54,59,60].
Increased sleep fragmentation and significantly longer circadian
period in activity in prion protein null mutants [65].
doi:10.1371/journal.pgen.1000040.t001
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kinase I epsilon (CKIe; OMIM *600863) and results in hypopho-
sphorylated PER2 in vitro. Transgenic mice expressing this
mutation had an advanced phase of activity in a light–dark
schedule and a short free-running period of activity [102]. A
second mis-sense mutation was found in CKId (OMIM *600864)
itself [92], the mutation resulting in reduced enzymatic activity in
vitro. Again, the phenotype in a mouse transgenic line mimicked
that of the human individuals.
Conflicts between internal biological clocks and environmental
(solar) and social clocks should be evident in individuals with
extreme diurnal preferences, and this could have the potential to
disrupt homeostatic processes and behaviours affected by them. In
fact, Xu et al. [92] observed that four out of five patients with
FASPS showed either evidence of the clinical features of, or a
history of, depression. Observations such as this and the hypothesis
that certain genetic susceptibility factors are shared across the
psychosis spectrum [103] have led several groups to investigate
clock gene associations in a number of mood disorders and
psychoses. The most evident example is in SAD. Partonen et al.
[104] found that SAD was associated with SNP variants in PER2,
BMAL1 (OMIM *602550), and NPAS2 (OMIM *603347) with
additive effects from combined risk genotypes. An earlier study
had also identified significant associations between diurnal
preference and SAD with a significant effect of NPAS2 471 Leu
on disease susceptibility [105].
Investigations into clock gene associations with other affective
disorders are in their infancy. Although limited, there are a
number of indications warranting further investigation into
associations with bipolar disorder, schizoaffective disorder, schizo-
phrenia, and autism [106–111]. Variants of PER1 (OMIM
*602260), PER3, NPAS2, BMAL1, CLOCK (OMIM *601851),
and TIM (OMIM *603887) all showed specific associations with a
number of disorders. The promise of these pilot studies should
encourage more systematic studies in investigating the contribu-
tion of clock gene variants to the onset and severity of CNS
disorders.
Conclusions
Biological rhythms are undoubtedly disrupted in a spectrum of
CNS disorders. Establishing the contribution of clock genes to
cause and effect in these disorders has proven difficult.
Nevertheless, these investigations continue to be helped through
the systematic characterisation of behavioural phenotypes in
mouse circadian mutants, the identification of new genetic factors
that contribute to circadian and behavioural function, and the
investigations of clock gene polymorphisms in all CNS disease
areas. Continued investigation into these three areas should lead to
new insights into the causes and progression of neurological and
psychiatric disorders.
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